Specialty Pharmaceutical Organization Awards $1 Million Study to eResearchTechnology for Cardiac Safety Monitoring and Informati
04 June 2004 - 12:01AM
PR Newswire (US)
Specialty Pharmaceutical Organization Awards $1 Million Study to
eResearchTechnology for Cardiac Safety Monitoring and Information
Distribution Services Thorough Phase I ECG Study Identified as Key
to Approval PHILADELPHIA, June 3 /PRNewswire-FirstCall/ --
eResearchTechnology, Inc. (eRT) (NASDAQ:ERES), a leading provider
of centralized electrocardiographic (ECG) collection and
interpretation services, announced today that it has been awarded
approximately $1 million in cardiac safety monitoring and services
from a specialty pharmaceutical organization for one of its drug
candidates in clinical development. The award covers an extensive
Phase I study for which eRT is providing comprehensive support
including the provision, training and ongoing assistance required
for effective use of digital 12-lead Holter equipment designed to
facilitate 24-hour digital recording of cardiac safety data that is
subsequently provided to eRT for analysis. eRT will perform digital
collection, measurement, interpretation, review, and distribution
of cardiac safety data through its EXPeRT(R) workflow enabled data
handling technology, the first solution in production that was
designed explicitly to meet emerging international regulatory
guidance and technical standards. The study is targeted for
completion over a 90-day period. "We are delighted to have been
awarded this important study, which provides us the ability to
support this rapidly emerging specialty pharmaceutical organization
in a key commercialization initiative," said Scott Grisanti, senior
vice president of business development and chief marketing officer
at eRT. "eRT's extensive Thorough Phase I ECG Study experience,
combined with our scientific consulting and Clinical Pharmacology
Unit partnerships, enabled eRT to rapidly coordinate delivery of a
turnkey solution including study conduct, ECG core laboratory
services, scientific consulting and regulatory representation."
Based in Philadelphia, PA, eResearchTechnology, Inc.
(http://www.ert.com/) is a provider of technology and services to
the pharmaceutical, biotechnology and medical device industries on
a global basis. The company is a market leader in providing
centralized core-diagnostic electrocardiographic (ECG) technology
and services to evaluate cardiac safety in clinical development.
The company is also a leader in providing technology and services
to streamline the clinical trials process by enabling its customers
to automate the collection, analysis, and distribution of clinical
data in all phases of clinical development. Statements included in
this release may constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such statements involve a number of risks and uncertainties such as
competitive factors, technological development, market demand, and
the company's ability to obtain new contracts and accurately
estimate net revenues due to variability in size, scope and
duration of projects, and internal issues in the sponsoring client.
This award may be canceled by the sponsor at its sole discretion.
As a result, actual results may differ materially from any
financial outlooks stated herein. Further information on potential
factors that could affect the company's financial results can be
found in the company's Reports on Forms 10-K and 10-Q filed with
the Securities and Exchange Commission. DATASOURCE:
eResearchTechnology, Inc. CONTACT: Joan Sterlacci,
eResearchTechnology, Inc., +1-908-203-6473; or Matt Hayden, Hayden
Communications, +1-858-456-4533, for eResearchTechnology Web site:
http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Tech (MM) News Articles